B
BFRI
Biofrontera Inc
0.8580
+0.0630+7.92%Closed19:51 05/27 EDT
OPEN/PREV CLOSE0.8000/0.7950
TODAY RANGE0.8000-0.8580
VOL107.58K
MARKET CAP10.99M
52 WEEK RANGE0.5360-1.190
AVG VOL (3M)172.90K
% TURNOVER0.84%
TURNOVER0
P/E (TTM)-0.7733
% RANGE7.30%
EPS(TTM)-1.1095
P/E(FORWARD)-3.7304
P/B1.678
BVPS0.5112
DIVIDEND--
P/S0.2396
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.93M
SHARES OUTSTANDING12.80M
NEXT EARNINGS08/11-08/17
FREE FLOAT10.40M
LOT SIZE1
EX-DATE07/05/2023
News
Press Releases
Financial Reports
Profile
Benzinga·05/19 14:34
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Benzinga·05/19 14:32
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
TipRanks·05/19 13:35
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Dow Jones·05/19 12:51
Biofrontera Price Target Maintained With a $3.00/Share by Benchmark
Dow Jones·05/19 12:51
Biofrontera Cut to Speculative Buy From Buy by Benchmark
Reuters·05/19 10:53
BIOFRONTERA INC <BFRI.O>: BENCHMARK CUTS TO SPECULATIVE BUY FROM BUY
TipRanks·05/19 10:15
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
Reuters·05/19 07:56
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Seeking Alpha·05/14 19:40
Biofrontera GAAP EPS of -$0.41 misses by $0.33, revenue of $10.1M misses by $0.4M
Seeking Alpha·05/14 17:31
Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin
Benzinga·05/14 15:39
Transcript: Biofrontera Q1 2026 Earnings Conference Call
Same Industry
Name/Symbol
Change%
Price